Evidence map›Paper›PMID 24173618›Full record

ArticleJAMA psychiatry2013

Addressing risks to advance mental health research.

Ana S Iltis, Sahana Misra, Laura B Dunn, Gregory K Brown, Amy Campbell, Sarah A Earll, Anne Glowinski, Whitney B Hadley, Ronald Pies, James M Dubois

Abstract read
In one paragraph

Article in JAMA psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Whose story is it? Mental health consumer and carer views on carer participation in research.Health expectations : an international journal of public participation in health care and health policy · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Expanding Access to Cancer Clinical Trials for Patients With Mental Illness.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ana S IltisCenter for Bioethics, Health, and Society and Department of Philosophy, Wake Forest University, Winston-Salem, North Carolina.
Sahana Misra
Laura B Dunn
Gregory K Brown
Amy Campbell
Sarah A Earll
Anne Glowinski
Whitney B Hadley
Ronald Pies
James M Dubois

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Best Practices in Mental Health Research Ethics Conference SeriesR13MH079690 · NIMH · SAINT LOUIS UNIVERSITY · PI DUBOIS, JAMES M · 2007 to 2010
$190k
NCATS NIH HHS UL1 TR000448NIMH NIH HHS 1R13MH079690NIMH NIH HHS R13 MH079690
6 · The paper itself

Abstract

importanceRisk communication and management are essential to the ethical conduct of research, yet addressing risks may be time consuming for investigators and institutional review boards may reject study designs that seem too risky. This can discourage needed research, particularly in higher-risk protocols or those enrolling potentially vulnerable individuals, such as those with some level of suicidality. Improved mechanisms for addressing research risks may facilitate much needed psychiatric research.

objectiveTo provide mental health researchers with practical approaches to (1) identify and define various intrinsic research risks, (2) communicate these risks to others (eg, potential participants, regulatory bodies, and society), (3) manage these risks during the course of a study, and (4) justify the risks. EVIDENCE REVIEW: As part of a National Institute of Mental Health-funded scientific meeting series, a public conference and a closed-session expert panel meeting were held on managing and disclosing risks in mental health clinical trials. The expert panel reviewed the literature with a focus on empirical studies and developed recommendations for best practices and further research on managing and disclosing risks in mental health clinical trials. No institutional review board-review was required because there were no human subjects.

findingsChallenges, current data, practical strategies, and topics for future research are addressed for each of 4 key areas pertaining to management and disclosure of risks in clinical trials: identifying and defining risks, communicating risks, managing risks during studies, and justifying research risks. CONCLUSIONS AND RELEVANCE: Empirical data on risk communication, managing risks, and the benefits of research can support the ethical conduct of mental health research and may help investigators better conceptualize and confront risks and to gain institutional review board-approval.

Indexed as

Biomedical ResearchClinical Trials as TopicEthics Committees, ResearchGuidelines as TopicHumansInformed ConsentMental HealthNational Institute of Mental Health (U.S.)Risk AssessmentUnited States

Identifiers

PMID24173618
PMCPMC4482112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.